Clinical Significance of Neoadjuvant Chemotherapy With Gemcitabine Plus S-1 for Resectable Pancreatic Ductal Adenocarcinoma

Background/Aim: Little is known about the efficacy of neoadjuvant chemotherapy (NAC) with gemcitabine plus S-1 (GS) for patients with resectable pancreatic ductal adenocarcinoma (R-PDAC). The aim of this study was to investigate differences in the long-term outcome of patients with R-PDAC undergoing...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:In Vivo
Päätekijät: SUZUKI, TAKASHI, MORI, SHOZO, SHIMIZU, TAKAYUKI, TAGO, KAZUMA, HARADA, NOBUHIRO, PARK, KYUNG-HWA, SAKURAOKA, YUHKI, SHIRAKI, TAKAYUKI, ISO, YUKIHIRO, AOKI, TAKU, KUBOTA, KEIICHI
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: International Institute of Anticancer Research 2019
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6899096/
https://ncbi.nlm.nih.gov/pubmed/31662534
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.11700
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia